Yehui Tan: Clinical Trials

3 trials sponsored by Yehui Tan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2
Phase 31Recruiting 1

Follow Yehui Tan: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes
VEN (Venetoclax) - Myelodysplastic Neoplasms, Transplantation
Phase 2RecruitingYehui Tan462025-07-012025-08-08
Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia
Intermediate-dose Cytarabine in Combination with Venetoclax - Acute Myeloid Leukemia (AML), Elderly
Phase 3RecruitingYehui Tan682025-06-012025-08-08
Study on Optimizing the Treatment of Patients With Acute Myeloid Leukemia Based on Early Peripheral Blood Minimal Residual Disease
Venetoclax - Acute Myeloid Leukemia (AML)
Phase 2RecruitingYehui Tan702025-06-012025-08-08

Conditions studied

Leukemia, Myeloid, Acute (2)

Interventions

venetoclax (3)  ·  Azacitidine (1)

Countries

China (3)